HYPERA SA Stock Price (OTCMKTS:HYPMY)

Add to My Stocks
$6.93 $0.38 (5.8%) HYPMY stock closing price Sep 20, 2018 (Closing)
Prev Close* : $6.55
Market Cap:
$4.22B
Day Low: $6.74
52 Week Low: $6.31
Open: $6.88
Volume: -
Day High: $6.98
52 Week High: $11.98
Dividend:
0.26

Latest Stock Market News

Latest Articles

HYPMY Stockcharts

View HYPMY PE ratio, PS ratio stocks charts and compare with peers.
HYPMY Chart
Note: Compare HYPERA SA stock price history with the index and industry peers.

HYPERA SA Valuation

PE ratio
(price earnings ratio)
15.98
PS ratio (
price to sales ratio
)
4.16
PB ratio (
price to book ratio
)
-999.0000

HYPERA SA Returns

ROE
(return on equity)
-

HYPERA SA Financial Ratios

Asset Turnover
-
Receivables Turnover
-
Debt to Equity
-
Dividend Yield
9.77%

HYPMY Industry Peers

Company Price Change (%)
Ariad Pharma (ARIA)23.990 (0%)
Anacor Pharma (ANAC)99.20 (0%)
Takeda Pharma (TKPYY)20.980.43 (2.01%)
Sanofi (SNY)43.90.06 (0.14%)
Bayer Ag (BAYRY)21.690.23 (1.07%)
Johnson & Johnson (JNJ)140.460.08 (0.06%)
Astrazeneca (AZN)37.30.19 (0.51%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MOLECULAR TEMPL (MTEM)6.252.15 (52.44%)
Neptune Tech. & Bio. (NEPT)4.710.44 (10.3%)
Infinity Pharma (INFI)2.310.18 (8.45%)
Pacira Pharma (PCRX)51.353.5 (7.31%)
Aratana Therapeutics (PETX)5.840.39 (7.16%)
Achaogen (AKAO)4.560.28 (6.54%)
La Jolla Pharma (LJPC)22.071.12 (5.35%)
Top gainers from Medical-Drugs industry
* As of Sep 20, 2018
CompanyPriceChange (%)
PTC Therapeutics (PTCT)45.371.82 (3.86%)
USANA Health Sciences (USNA)119.354.75 (3.83%)
Esperion Therapeutics (ESPR)45.571.69 (3.58%)
ArQule (ARQL)4.850.17 (3.39%)
Zogenix (ZGNX)47.051.6 (3.29%)
Nektar Therapeutics (NKTR)56.691.64 (2.81%)
Durect (DRRX)1.10.03 (2.65%)
Top losers from Medical-Drugs industry
* As of Sep 20, 2018

HYPERA SA Financial Statements

income statement20162015201420132012
Net Sales or Revenues942.88M902.7M2B1.98B1.99B
Net Income336.75M170.93M176.13M119.65M104.97M
Total Operating Expense393.63M404.92M885.06M862.72M843.24M
View HYPERA SA income statement
balance sheet20162015201420132012
Total Assets3.29B4.83B5.93B5.83B6.52B
Total Liabilities766.86M2.38B2.74B2.53B2.98B
Shareholders Equity2.53B2.45B3.19B3.3B3.54B
View HYPERA SA balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities-65.79M-190.22M44.79M-127.13M-81.57M
Net Cash from (used by) Operating Activities252.79M98.82M283.72M310.32M367.46M
Increase (Decrease) in Prop Plant And Equipment667.5M464.77M-76.45M-91.57M-88.66M
View HYPERA SA cash flow statement

HYPERA SA Stock Message Board

An investor needs to spend $6.93 to buy HYPMY stock, as the closing HYPERA SA stock price is $6.93. HYPERA SA market capitalization is $4.22B and it represents the total market value of HYPMY stock. HYPERA SA valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

For recognizing and analyzing the real performance of HYPERA SA stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume number in HYPERA SA stock quote data shows the number of shares traded. For Ex: 33,976 HYPERA SA shares were traded as of last trading day, as seen from HYPERA SA stock chart. The board of directors decide what percentage of a company's earnings will be paid out as dividends. HYPERA SA stock dividend was 0.26 during the last quarter. To check the historical stock price movement, all time high, and all time low of HYPMY, view HYPERA SA stock price history.